{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:00:35Z","timestamp":1765454435308,"version":"3.46.0"},"reference-count":42,"publisher":"Mattioli1885","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Introduction: As the pandemic plateaus, post-COVID alopecia is resurfacing in India. COVID-19 remains a pivotal cause of alopecia, and the diagnosis of post-COVID alopecia aids in better treatment outcomes. Objectives: To estimate the prevalence of post-COVID alopecia and to evaluate the association between alopecia and COVID severity among other factors. Methods: A retrospective cross-sectional study was conducted among patients admitted to the COVID ward. Patients willing to participate were asked to fill in a pretested semi-structured questionnaire, and the PSS-10 (Perceived Stress Scale) was used to evaluate stress. Data were analyzed using the SPSS version 24. Results: Prevalence of COVID-19-induced hair loss was 37.8%. Age, sex, COVID severity, and higher stress were the significant factors, with p-value &lt;0.05. Female sex, COVID severity, and high stress levels came to be significant independent predictors of hair loss. A majority of participants (46.9%) noticed hair loss within three months of contracting the disease. Conclusion: This study stands to be a pioneer project to investigate the prevalence of COVID-19-induced alopecia in India. The prevalence rate of 37.8% with a significant association with severity of COVID-19 highlights the importance of reviewing patient history to provide proper treatment and reassurance.<\/jats:p>","DOI":"10.5826\/dpc.1504a5417","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:22:20Z","timestamp":1761916940000},"page":"5417","source":"Crossref","is-referenced-by-count":0,"title":["Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity"],"prefix":"10.5826","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7035-8713","authenticated-orcid":false,"given":"Anshitha","family":"Vurimindi Kadudas","sequence":"first","affiliation":[{"name":"Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-3694","authenticated-orcid":false,"given":"Tina Priscilla","family":"Katta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, Leprosy Apollo Institute of Medical sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6064-3321","authenticated-orcid":false,"given":"Neha","family":"Gala","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8911-6760","authenticated-orcid":false,"given":"Anu","family":"Mohandas","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, BGS Medical College and Hospital, Adichunchanagiri University, BGS Vijnatham Campus, Nagarur Bengaluru, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7942-7477","authenticated-orcid":false,"given":"Manmohan","family":"Gavvala","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology, Leprosy Apollo Institute of Medical sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5414-7823","authenticated-orcid":false,"given":"Rishita","family":"Pogula","sequence":"additional","affiliation":[{"name":"Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8327-7993","authenticated-orcid":false,"given":"Sai Rashmitha","family":"Pagadala","sequence":"additional","affiliation":[{"name":"Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2682-5919","authenticated-orcid":false,"given":"Anvi","family":"K. Reddy","sequence":"additional","affiliation":[{"name":"Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2720-2255","authenticated-orcid":false,"given":"Spurthi","family":"Subramanyam","sequence":"additional","affiliation":[{"name":"Apollo Institute of Medical Sciences and Research, Apollo Health city Campus, Jubilee Hills, Hyderabad, Telangana, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27750","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"10.5826\/dpc.1504a5417_ref1","unstructured":"World Health Organization. WHO COVID-19 Dashboard. Accessed March 1, 2024. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c"},{"key":"10.5826\/dpc.1504a5417_ref2","doi-asserted-by":"crossref","unstructured":"Nalbandian A, Sehgal K, Gupta A, et al.: Post-acute COVID-19 syndrome. Nat Med. 2021, 27:601-615. DOI: 10.1038\/s41591-021-01283-z","DOI":"10.1038\/s41591-021-01283-z"},{"key":"10.5826\/dpc.1504a5417_ref3","doi-asserted-by":"crossref","unstructured":"Freeman EE, et al. The spectrum of COVID\u201119\u2011associated dermatologic manifestations: an international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020 Oct;83(4):1118\u20111129. DOI:10.1016\/j.jaad.2020.06.1016. Epub 2020 Jul 2. PMID: 32622888; PMCID: PMC7331510","DOI":"10.1016\/j.jaad.2020.06.1016"},{"key":"10.5826\/dpc.1504a5417_ref4","doi-asserted-by":"crossref","unstructured":"Abdulwahab RA, et al. Prevalence of hair loss after COVID\u201119 infection in the Makkah region, Saudi Arabia. Cureus. 2022 Sep 18;14(9):e29285. DOI:10.7759\/cureus.29285","DOI":"10.7759\/cureus.29285"},{"key":"10.5826\/dpc.1504a5417_ref5","doi-asserted-by":"crossref","unstructured":"Starace M, et al. Trichodynia and telogen effluvium in COVID\u201119 patients: results of an international expert opinion survey on diagnosis and management. JAAD Int. 2021 Dec;5:11\u201118. DOI:10.1016\/j.jdin.2021.07.006. Epub 2021 Aug 3. PMID: 34368790; PMCID: PMC8328568","DOI":"10.1016\/j.jdin.2021.07.006"},{"key":"10.5826\/dpc.1504a5417_ref6","doi-asserted-by":"crossref","unstructured":"Khrystyna N, Oksana K, Larysa S. Post COVID\u201119 telogen effluvium: what is the reason? InterConf. 2021;52:302\u2011306. DOI:10.51582\/interconf.21\u201122.04.2021.035","DOI":"10.51582\/interconf.21-22.04.2021.035"},{"key":"10.5826\/dpc.1504a5417_ref7","doi-asserted-by":"crossref","unstructured":"Rivetti N, Barruscotti S. Management of telogen effluvium during the COVID-19 emergency: Psychological implications. Dermatol Ther. 2020 Jul;33(4):e13648. DOI: 10.1111\/dth.13648. Epub 2020 Jun 5. PMID: 32445237; PMCID: PMC7267137.","DOI":"10.1111\/dth.13648"},{"key":"10.5826\/dpc.1504a5417_ref8","doi-asserted-by":"crossref","unstructured":"Turkmen D, Altunisik N, Sener S, Colak C. Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatol Ther. 2020 Nov;33(6):e13923. DOI: 10.1111\/dth.13923. Epub 2020 Jul 16. PMID: 32594627; PMCID: PMC7361059","DOI":"10.1111\/dth.13923"},{"key":"10.5826\/dpc.1504a5417_ref9","unstructured":"Sacchidanand S, Savitha AS, Shilpa K. IADVL Textbook of Dermatology 5th edition. Bhalani Publishing House; 2022."},{"key":"10.5826\/dpc.1504a5417_ref10","doi-asserted-by":"crossref","unstructured":"Wadhwa D, Monga A, Kumar N, Khullar G, Karmakar S, Khunger N. A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital. Dermatol Pract Concept. 2023 Oct 1;13(4):e2023263. DOI: 10.5826\/dpc.1304a263. PMID: 37992388; PMCID: PMC10656157.","DOI":"10.5826\/dpc.1304a263"},{"key":"10.5826\/dpc.1504a5417_ref11","doi-asserted-by":"crossref","unstructured":"Mieczkowska K et al., (2021). Telogen effluvium: a sequela ofCOVID-19. Int J Dermatol. 2021 Jan;60(1):122-124. DOI: 10.1111\/ijd.15313.Epub 2020 Nov 23. PMID: 33226117; PMCID: PMC7753411","DOI":"10.1111\/ijd.15313"},{"key":"10.5826\/dpc.1504a5417_ref12","doi-asserted-by":"crossref","unstructured":"Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2022 Aug;191(4):1677-1681. DOI: 10.1007\/s11845-021-02754-5. Epub 2021 Aug 31. PMID: 34467470; PMCID: PMC8407603.","DOI":"10.1007\/s11845-021-02754-5"},{"key":"10.5826\/dpc.1504a5417_ref13","doi-asserted-by":"crossref","unstructured":"Tr\u00fceb RM, Dutra Rezende H, Gavazzoni Dias MFR. What can the hair tell us about COVID-19? Exp Dermatol. 2021 Feb;30(2):288-290. DOI: 10.1111\/exd.14259. Epub 2020 Dec 28. PMID: 33316115.","DOI":"10.1111\/exd.14259"},{"key":"10.5826\/dpc.1504a5417_ref14","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-de-Las-Pe\u00f1as C, Palacios-Ce\u00f1a D, G\u00f3mez-Mayordomo V, et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study. J Infect. 2021 Aug;83(2):237-279. DOI: 10.1016\/j.jinf.2021.04.036. Epub 2021 May 11. PMID: 33984399; PMCID: PMC8110627.","DOI":"10.1016\/j.jinf.2021.04.036"},{"key":"10.5826\/dpc.1504a5417_ref15","doi-asserted-by":"crossref","unstructured":"Raj SVA, Jacob A, Ambu V, Wilson T, Renuka R. Post COVID-19 clinical manifestations and its risk factors among patients in a Northern District in Kerala, India. J Family Med Prim Care. 2022 Sep;11(9):5312-5319. DOI: 10.4103\/jfmpc.jfmpc_131_22. Epub 2022 Oct 14. PMID: 36505604; PMCID: PMC9731023.","DOI":"10.4103\/jfmpc.jfmpc_131_22"},{"key":"10.5826\/dpc.1504a5417_ref16","doi-asserted-by":"crossref","unstructured":"Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021 Jan;27(1):89-95. DOI: 10.1016\/j.cmi.2020.09.023. Epub 2020 Sep 23. PMID: 32979574; PMCID: PMC7510771.","DOI":"10.1016\/j.cmi.2020.09.023"},{"key":"10.5826\/dpc.1504a5417_ref17","doi-asserted-by":"crossref","unstructured":"Kutlu \u00d6, Metin A. Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e14096. DOI: 10.1111\/dth.14096. Epub 2020 Aug 14. PMID: 32869938.","DOI":"10.1111\/dth.14096"},{"key":"10.5826\/dpc.1504a5417_ref18","doi-asserted-by":"crossref","unstructured":"Abrantes TF, Artounian KA, Falsey R, et al. Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol. 2021 Oct;85(4):975-976. DOI: 10.1016\/j.jaad.2021.07.021. Epub 2021 Jul 21. PMID: 34302903; PMCID: PMC8294706.","DOI":"10.1016\/j.jaad.2021.07.021"},{"key":"10.5826\/dpc.1504a5417_ref19","doi-asserted-by":"crossref","unstructured":"Babaei K, Kavoussi H, Rezaei M, Kavoussi R. Characteristics of telogen effluvium in COVID-19 in western Iran. An Bras Dermatol. 2021;96(6):688-692. DOI:10.1016\/j.abd.2021.05.006. PMID: 34593265; PMCID: PMC8440166.","DOI":"10.1016\/j.abd.2021.05.006"},{"key":"10.5826\/dpc.1504a5417_ref20","unstructured":"Malkud S. Telogen Effluvium: A Review. J Clin Diagn Res. 2015 Sep;9(9):WE01-3. DOI: 10.7860\/JCDR\/2015\/15219.6492. Epub 2015 Sep 1. PMID: 26500992; PMCID: PMC4606321."},{"key":"10.5826\/dpc.1504a5417_ref21","doi-asserted-by":"crossref","unstructured":"Rebora A. Telogen effluvium: a comprehensive review. Clin Cosmet Investig Dermatol. 2019 Aug 21;12:583-590. DOI: 10.2147\/CCID.S200471. PMID: 31686886; PMCID: PMC6709511.","DOI":"10.2147\/CCID.S200471"},{"key":"10.5826\/dpc.1504a5417_ref22","doi-asserted-by":"crossref","unstructured":"Chu C-B, Yang C-C. Dengue-associated telogen effluvium: a report of 14 patients. Dermatol Sin. 2017;35(3):124-126. DOI:10.1016\/j.dsi.2017.03.005.","DOI":"10.1016\/j.dsi.2017.03.005"},{"key":"10.5826\/dpc.1504a5417_ref23","unstructured":"Shahram Seyfi, et al. Prevalence of telogen effluvium hair loss in COVID\u201119 patients and its relationship with disease severity. J Med Life. 2022 May;15(5)."},{"key":"10.5826\/dpc.1504a5417_ref24","doi-asserted-by":"crossref","unstructured":"M\u00fcller-Ramos P, Ianhez M, Silva de Castro CC, et al. Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. International Journal of Dermatology. 2022 May;61(5):e162-e164. DOI: 10.1111\/ijd.16041. PMID: 35080250","DOI":"10.1111\/ijd.16041"},{"key":"10.5826\/dpc.1504a5417_ref25","doi-asserted-by":"crossref","unstructured":"Monari P, Gualdi G, Bettoni G, et al. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication. J Clin Med. 2022 Feb 24;11(5):1234. DOI: 10.3390\/jcm11051234. PMID: 35268325; PMCID: PMC8911426.","DOI":"10.3390\/jcm11051234"},{"key":"10.5826\/dpc.1504a5417_ref26","unstructured":"Kalner S, Vergilis I. Retrospective Study of Covid Related Hair Loss. J Drugs Dermatol. 2022 Jul 1;21(7):724-727. DOI: 10.36849\/JDD.6661. PMID: 35816057."},{"key":"10.5826\/dpc.1504a5417_ref27","doi-asserted-by":"crossref","unstructured":"Wei KC, Yang CC. Hair loss and COVID-19. Dermatol Sin. 2021;39(4):167\u2013168. DOI:10.4103\/ds.ds_52_21.","DOI":"10.4103\/ds.ds_52_21"},{"key":"10.5826\/dpc.1504a5417_ref28","doi-asserted-by":"crossref","unstructured":"Olds H, Liu J, Luk K, Lim HW, Ozog D, Rambhatla PV. Telogen effluvium associated with COVID-19 infection. Dermatol Ther. 2021 Mar;34(2):e14761. DOI: 10.1111\/dth.14761. Epub 2021 Jan 14. PMID: 33405302; PMCID: PMC7883200.","DOI":"10.1111\/dth.14761"},{"key":"10.5826\/dpc.1504a5417_ref29","doi-asserted-by":"crossref","unstructured":"Fahmy DH, El-Amawy HS, El-Samongy MA, et al. COVID-19 and dermatology: a comprehensive guide for dermatologists. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1388-1394. DOI: 10.1111\/jdv.16545. Epub 2020 Jun 10. PMID: 32428303; PMCID: PMC7276795.","DOI":"10.1111\/jdv.16545"},{"key":"10.5826\/dpc.1504a5417_ref30","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u2013280.e8. DOI:10.1016\/j.cell.2020.02.052. PMID: 32142651; PMCID: PMC7102627.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"10.5826\/dpc.1504a5417_ref31","doi-asserted-by":"crossref","unstructured":"Alkeraye S, Alrashidi A, Alotaibi NS, et al. The Association Between Hair Loss and COVID-19: The Impact of Hair Loss After COVID-19 Infection on the Quality of Life Among Residents in Saudi Arabia. Cureus. 2022 Oct 13;14(10):e30266. DOI: 10.7759\/cureus.30266. PMID: 36381793; PMCID: PMC9653091.","DOI":"10.7759\/cureus.30266"},{"key":"10.5826\/dpc.1504a5417_ref32","doi-asserted-by":"crossref","unstructured":"Popescu MN, Berteanu M, Beiu C, et al. Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium. Clin Cosmet Investig Dermatol. 2022 Apr 22;15:735-743. DOI: 10.2147\/CCID.S359052. PMID: 35497690; PMCID: PMC9042074.","DOI":"10.2147\/CCID.S359052"},{"key":"10.5826\/dpc.1504a5417_ref33","doi-asserted-by":"crossref","unstructured":"Jafferany M, Patel A. Trichopsychodermatology: The Psychiatric and Psychosocial Aspects of Hair Disorders. Dermatol Ther. 2020 Jan;33(1):e13168. DOI: 10.1111\/dth.13168. Epub 2019 Nov 25. PMID: 31714654.","DOI":"10.1111\/dth.13168"},{"key":"10.5826\/dpc.1504a5417_ref34","doi-asserted-by":"crossref","unstructured":"Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e181-e183. DOI: 10.1111\/jdv.17045. Epub 2020 Dec 9. PMID: 33220124; PMCID: PMC7753386.","DOI":"10.1111\/jdv.17045"},{"key":"10.5826\/dpc.1504a5417_ref35","doi-asserted-by":"crossref","unstructured":"Gupta PK, Singh S, Mahour P, et al. Mental health outcome in hospitalized COVID-19 patients: An observational analysis from North Indian tertiary care hospital. Clin Epidemiol Glob Health. 2023 Jan-Feb;19:101209. DOI: 10.1016\/j.cegh.2022.101209. Epub 2023 Jan 1. PMID: 36619652; PMCID: PMC9805410.","DOI":"10.1016\/j.cegh.2022.101209"},{"key":"10.5826\/dpc.1504a5417_ref36","doi-asserted-by":"crossref","unstructured":"Zandifar A, Badrfam R, Yazdani S, et al. Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19. J Diabetes Metab Disord. 2020 Oct 29;19(2):1431-1438. DOI: 10.1007\/s40200-020-00667-1. PMID: 33145259; PMCID: PMC7594988.","DOI":"10.1007\/s40200-020-00667-1"},{"key":"10.5826\/dpc.1504a5417_ref37","doi-asserted-by":"crossref","unstructured":"Carola V, Vincenzo C, Morale C, Pelli M, Rocco M, Nicolais G. Psychological health in COVID-19 patients after discharge from an intensive care unit. Front Public Health. 2022 Aug 12;10:951136. DOI: 10.3389\/fpubh.2022.951136. PMID: 36033791; PMCID: PMC9411785.","DOI":"10.3389\/fpubh.2022.951136"},{"key":"10.5826\/dpc.1504a5417_ref38","doi-asserted-by":"crossref","unstructured":"Lee AM, Wong JG, McAlonan GM, et al. Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. 2007 Apr;52(4):233-40. DOI: 10.1177\/070674370705200405. PMID: 17500304.","DOI":"10.1177\/070674370705200405"},{"key":"10.5826\/dpc.1504a5417_ref39","unstructured":"Indian Council of Medical Research. Clinical guidance and management of adult COVID-19 patients. Indian Council of Medical Research. Published March 2023. Accessed March 1, 2024. https:\/\/www.icmr.gov.in\/pdf\/covid\/techdoc\/COVID_Clinical_Management_19032023.pdf"},{"key":"10.5826\/dpc.1504a5417_ref40","unstructured":"New Hampshire Department of Health & Human Services. Perceived Stress Scale. New Hampshire Department of Health & Human Services. Accessed March 1, 2024. https:\/\/das.nh.gov\/wellness\/docs\/percieved stress scale.pdf"},{"key":"10.5826\/dpc.1504a5417_ref41","doi-asserted-by":"crossref","unstructured":"Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020 Dec;81(6):e4-e6. DOI: 10.1016\/j.jinf.2020.08.029. Epub 2020 Aug 25. PMID: 32853602; PMCID: PMC7445491.","DOI":"10.1016\/j.jinf.2020.08.029"},{"key":"10.5826\/dpc.1504a5417_ref42","doi-asserted-by":"crossref","unstructured":"Hussain N, Agarwala P, Iqbal K, et al. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol. 2022 Apr;94(4):1391-1401. DOI: 10.1002\/jmv.27534. Epub 2021 Dec 28. PMID: 34931698.","DOI":"10.1002\/jmv.27534"}],"container-title":["Dermatology Practical &amp; Conceptual"],"original-title":[],"link":[{"URL":"https:\/\/mail.dpcj.org\/index.php\/dpc\/article\/download\/5417\/3223","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mail.dpcj.org\/index.php\/dpc\/article\/download\/5417\/3606","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mail.dpcj.org\/index.php\/dpc\/article\/download\/5417\/3223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T11:54:13Z","timestamp":1765454053000},"score":1,"resource":{"primary":{"URL":"https:\/\/mail.dpcj.org\/index.php\/dpc\/article\/view\/5417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5826\/dpc.1504a5417","relation":{"has-manifestation":[{"id-type":"other","id":"1-81-5417-g3223","asserted-by":"subject"},{"id-type":"other","id":"1-81-5417-g3606","asserted-by":"subject"}],"is-part-of":[{"id-type":"doi","id":"10.5826\/dpc.1504a%a","asserted-by":"subject"}]},"ISSN":["2160-9381"],"issn-type":[{"type":"electronic","value":"2160-9381"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"15"}}